Vascular endothelial growth factor (VEGF) and soluble VEGF receptor 1 (sFlt-1) levels in early and mature human milk from mothers of preterm versus term infants

Journal of Human Lactation

Volumn 28, Issue 4, 2012, Pages 522-528

  Loui, Andrea ^a   Eilers, Elisabeth ^b   Strauss, Evelyn ^a   Pohl Schickinger, Anja ^a   Obladen, Michael ^a   Koehne, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

angiogenesis; breast feeding; growth; human milk; lactation; neurodevelopment; preterm infant; sFlt 1; VEGF

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST MILK; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; LACTATION; LONGITUDINAL STUDY; MALE; METABOLISM; NEWBORN; PILOT STUDY; PREMATURITY;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTATION; LONGITUDINAL STUDIES; MALE; MILK, HUMAN; PILOT PROJECTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84867749121     PISSN: 08903344     EISSN: 15525732     Source Type: Journal    
DOI: 10.1177/0890334412447686     Document Type: Article

References (33)

1. Kobata R, Tsukahara H, Ohshima Y, et al. High levels of growth factors in human breast milk. Early Hum Dev. 2008 ; 84: 67-69
2. Savino F, Liguori SA. Update of breast milk hormones: leptin, ghrelin and adiponectin. Clin Nutr. 2008 ; 27: 42-47
3. Lucas A, Morley R, Cle TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet. 1992 ; 339: 261-264
4. Semba RD, Juul SE. Erythropoietin in human milk: physiology and role in infant health. J Human Lact. 2002 ; 18: 252-261
5. Milsom SR, Blum WF, Gunn AJ. Temporal changes in insulin-like growth factors I and II and in insulin-like growth factor binding proteins 1, 2, and 3 in human milk. Horm Res. 2008 ; 69: 307-311
6. Oslislo A, Czuba Z, Slawska H, Kazmierczak W, Krol W. Decreased human milk concentration of epidermal growth factor after preterm delivery of intrauterine growth-restricted newborns. J Pediatr Gastroenterol Nutr. 2007 ; 44: 464-467
7. Siafakas CG, Anatolitou F, Fusunyan RD, Walker WA, Sanderson IR. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res. 1999 ; 45: 652-657
8. Kan E, Roberts G, Anderson PJ, Doyle LW. The association of growth impairment with neurodevelopmental outcome at eight years of age in very preterm children. Early Hum Dev. 2008 ; 84: 409-416
9. Vanhaesebrouck P, Allegaert K, Bottu J, et al. Extremely preterm infants in Belgium study group. The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium. Pediatrics. 2004 ; 114: 663-675
10. Kashyap S. Enteral intake for very low birth weight infants: what should the composition be?. Sem Perinatol. 2007 ; 31: 74-82
11. Corpeleijn WE, van Vliet I, de Gast-Bakker DH, et al. Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates. J Pediatr Gastroenterol Nutr. 2008 ; 46: 184-190
12. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut. 1996 ; 39: 262-266
13. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989 ; 161: 851-858
14. Cameliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet. 2003 ; 4: 710-720
15. Ferrera N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004 ; 25: 581-611
16. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci. 1993 ; 90: 10705-10709
17. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991 ; 5: 1806-1814
18. Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 30: S38-42
19. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Molec Biol. 2006 ; 39: 469-478
20. Hashimoto K, Ohkura T. Vascular endothelial growth factor in human milk. Br J Biomed Sci. 2000 ; 57: 215-217
21. Vuorela P, Andersson S, Carpén O, Ylikorkala O, Halmesmäki E. Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr. 2000 ; 72: 1196-1201
22. Nishimura S, Maeno N, Matsuo K, et al. Human lactiferous mammary gland cells produce vascular endothelial growth factor (VEGF) and express the VEGF receptors, Flt-1 and KDR/ Flk-1. Cytokine. 2002 ; 18: 191-198
23. Ozgurtas T, Aydin I, Turan O, et al. Vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-I and platelet-derived growth factor levels in human milk of mothers with term and preterm neonates. Cytokine. 2010 ; 50: 192-194
24. Weber A, Loui A, Jochum F, Bührer C, Obladen M. Breast milk from mothers of very low birth weight infants: variability in fat and protein content. Acta Paediatr. 2001 ; 90: 772-775
25. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatrics. 2003 ; 3: 13-23
26. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 ; 150: 76-85
27. Kong SY, Lee HL, Eom HS, et al. Reference intervals for circulating angiogenic cytokines. Clin Chem Lab Med. 2008 ; 46: 545-550
28. Smythe J, Fox A, Fisher N, Frith E, Harris AL, Watt SM. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood. Tissue Eng Part C Methods. 2008 ; 14: 59-67
29. Pepper MS, Baetens D, Mandriota SJ, et al. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn. 2000 ; 218: 507-524
30. Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol. 2006 ; 195: 1668-1673
31. Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998 ; 59: 1540-1548
32. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop pre-eclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008 ; 21: 9-23
33. Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP, Hassiakos D. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev. 2006 ; 82: 235-239